Cognitive-motor Telerehabilitation in MS
CoMoTeMS
2 other identifiers
interventional
90
1 country
2
Brief Summary
The primary goal of this project is providing evidence that a home-based combined cognitive-motor training program improves cognition in persons with multiple sclerosis (MS), compared to single cognitive and motor rehabilitation. Secondary goals are to assess the effects on walking performance and to identify the mechanisms of improvement and predictors of treatment response. The main backbone of this project will be a randomized controlled two-centre clinical trial, in which an at-home computerised cognitive-motor rehabilitation program using telemedicine aimed at improving working memory in persons with MS will be evaluated. Based on the information gathered during this trial, possible mechanisms of improvement will be identified by analysing anatomical and neurophysiological changes on structural MRI and resting-state and task-related EEG before and after rehabilitation. Furthermore, factors that can predict treatment response to the rehabilitation program will be identified.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Sep 2022
Longer than P75 for not_applicable multiple-sclerosis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2022
CompletedFirst Posted
Study publicly available on registry
May 2, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
April 2, 2025
March 1, 2025
4.7 years
April 14, 2022
March 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Digit span backwards
Measure of working memory
0 weeks, 12 weeks, 24 weeks, 64 weeks
Secondary Outcomes (14)
Change in Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
0 weeks, 12 weeks, 24 weeks, 64 weeks
Change in Corsi backwards
0 weeks, 12 weeks, 24 weeks, 64 weeks
Change in Expanded Disability Status Scale (EDSS)
0 weeks, 12 weeks, 24 weeks, 64 weeks
Change in 6-Minute Walk Test (6MWT)
0 weeks, 12 weeks, 24 weeks, 64 weeks
Change in 25-Foot Walk Test (25FWT)
0 weeks, 12 weeks, 24 weeks, 64 weeks
- +9 more secondary outcomes
Other Outcomes (8)
Change in Hospital Anxiety and Depression Scale (HADS)
0 weeks, 12 weeks, 24 weeks, 64 weeks
Change in Fatigue Scale for Motor and Cognitive functions (FSMC)
0 weeks, 12 weeks, 24 weeks, 64 weeks
Change in Visual Analogue Scale (VAS)
0 weeks, 12 weeks, 24 weeks, 64 weeks
- +5 more other outcomes
Study Arms (3)
Cognitive-motor training group
EXPERIMENTALCognitive training group
ACTIVE COMPARATORMotor training group
ACTIVE COMPARATORInterventions
For the cognitive treatment intervention the widely used cognitive training program RehaCom will be used. This is a computer-aided program with more than 30 modules focusing on different domains of cognition. RehaCom has shown improvements in verbal learning, visuospatial memory, information processing speed, attention, executive functions, depression, fatigue and quality of life in PwMS (PMID 31927200, 28116167, 19825502, 23192417). Patients will train on their home computer without direct therapist supervision, using three RehaCom modules that are focused on improving working memory. Both patients in the combined intervention and the cognitive intervention group will be doing a 45-minute computer session respectively one and two days per week for a total of 12 weeks.
For the motor treatment intervention a patient-tailored aerobic training program will be used. Based on their baseline physical activity level patients can choose out of a number of aerobic activities of either mild, moderate or strenuous intensity, with a total training time of 90 minutes for the motor intervention group and 45 minutes for the combined intervention group, divided over at least two training sessions per week of at least 15 minutes per session. The training will be carried out individually at home, without therapist supervision. All physical activities will be logged using the sport watch equipped with a heart rate sensor and an accelerometer. Training intensity will be assessed using the patient's heart rate and the Rating of Perceived Exertion scale.
Eligibility Criteria
You may qualify if:
- Clinically definite multiple sclerosis (revised McDonald criteria 2017)
- Expanded Disability Status Scale (EDSS) below 6.0
- Digit span backwards z-score between \[-3 and -0.5\] standard deviations below the median of the normative values
- Age between 18 and 65
- Able to safely perform motor rehabilitation in the home situation (assessed by rehabilitation physician and/or occupational or physiotherapist)
You may not qualify if:
- Less than one month post-exacerbation
- Major psychiatric or medical disorder that could influence cognitive functions
- Combined vision with optimal correction below 0.6 on Snellen Visual Acuity Test
- Unable or unwilling to undergo EEG or MRI
- Refusing informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universitair Ziekenhuis Brussel
Brussels, Belgium
National MS Center Melsbroek
Melsbroek, Belgium
Related Publications (1)
Van Laethem D, Van de Steen F, Kos D, Naeyaert M, Van Schuerbeek P, D'Haeseleer M, D'Hooghe MB, Van Schependom J, Nagels G. Cognitive-motor telerehabilitation in multiple sclerosis (CoMoTeMS): study protocol for a randomised controlled trial. Trials. 2022 Sep 14;23(1):778. doi: 10.1186/s13063-022-06697-9.
PMID: 36104820DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guy Nagels
Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The study will be double-blinded: patients will not be made aware of the rationale and predictions of the study. The teleconsultations will be carried out by a trained MS nurse, while the baseline and follow-up testing and analyses are carried out by an investigator who is blinded to the treatment allocation of the patients.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2022
First Posted
May 2, 2022
Study Start
September 1, 2022
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2027
Last Updated
April 2, 2025
Record last verified: 2025-03